TrumpRx Site To Open In 2026 With Pfizer Drugs At Lower Prices For Medicaid Patients

Benzinga

Trump struck a deal with Pfizer to sell discounted drugs to Medicaid patients through a new federal site called TrumpRx. Pfizer will get a three-year exemption from upcoming pharma tariffs, offering discounts averaging 50%. Critics argue the program may not yield broad savings and warn tariffs could still push prices higher.

Transcript

00:00It's Benzinga, bringing Wall Street to Main Street.

00:02President Trump announced a deal with Pfizer to sell its drugs at lower prices for Medicaid

00:06patients, according to NBC News. As part of the agreement, Pfizer will sell some medicines

00:10through a new federal direct-to-consumer website called TrumpRx. Pfizer's deal with the White

00:15House grants it a three-year exemption from Trump's planned tariffs on pharmaceuticals

00:19made overseas, set to begin Wednesday. The company sent discounts of an average 50%

00:23to reach up to 85% on certain brand-name drugs. The program expected to launch in early 2026

00:29will initially serve Medicaid patients but will be able to all Americans, who experts

00:32question whether it will provide meaningful savings for most. Critics said direct-to-consumer

00:36sales mainly benefit the uninsured and warn that broader administration policies

00:41spending 100% drug tariffs could drive prices higher.

00:44For all things money, visit Benzinga.com.

Category

Transcript

Comments

Recommended